ORCID as entered in ROS
https://orcid.org/0000-0001-9377-8521
Select Publications
Conference Papers
, 2002, 'Percutaneous imaging guided radio frequency in situ ablation (RFA) of 44 pulmonary metastases in 20 patients with colorectal cancer', in Australian and New Zealand Journal of Surgery, Wiley-Blackwell Publishing Asia, Australia, pp. 52 - 52, presented at
, 2002, 'Radiologically placed temporary hepatic artery catheter for treatment of liver cancer', in Australian and New Zealand Journal of Surgery, Wiley-Blackwell Publishing Asia, Australia, pp. 54 - 54, presented at
Conference Posters
, 2014, '187: The expression of the human Sprouty protein-1 (hSpry1) inversely correlates with proliferation, migration and invasion of the SKOV-3 and 1A9 human ovarian cancer cells', Vol. 50, pp. S42 - S42, http://dx.doi.org/10.1016/s0959-8049(14)50160-8
Conference Presentations
, 2014, 'A NOVEL AMINOACETONITRILE DERIVATIVE, MONEPANTEL (AAD-1566) INHIBITS OVARIAN CANCER CELL GROWTH THROUGH SUPPRESSION MTORC1 AND INDUCTION OF AUTOPHAGY', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'MONEPANTEL (AAD-1566) INHIBITS MAMMALIAN TARGET OF RAPAMYCIN SIGNALING THROUGH INHIBITION OF MAJOR COMPONENTS IN THE MTOR AXIS AND INDUCTION OF AUTOPHAGY IN OVARIAN CANCER CELLS', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500280&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Minocycline regulates hypoxia-inducible factor-1 alpha expression through the induction of its degradation in ovarian cancer: in vitro and in vivo studies', presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-3689
, 2011, 'Case Presentations', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011
, 2011, 'Combination of liver resection with regional chemotherapy and/or radiofrequency ablation', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011
, 2011, 'Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011
, 2011, 'How to start PC program', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011
, 2011, 'Selection criteria for surgical treatment of liver metastases', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011
, 2011, 'Liver-Directed therapy as treatment of hepatic progression following surgical extirpaton of neuroendocrine neoplasm hepatic metastasis.', presented at Annual Cancer Symposium Society of Surgical Oncology, San Antonio, Texas, USA, 03 March 2011 - 07 March 2011
, 2011, 'Optimizing the surgical effort in patients with advanced neuroendocrine tumor hepatic metastases by combining hepatic resection with ablation: A critical analysis of 40 patients.', presented at Annual Cancer Symposium Society of Surgical Oncology, San Antonio, Texas, USA, 03 March 2011 - 07 March 2011
, 2010, 'Evaluation of best supportive care and systemic chemotherapy as treatment for peritoneal carcinomatosis of colorectal origin', presented at 7th International Workshop on Peritoneal Surface Malignancy, Uppsala, Sweden, 08 September 2010 - 10 September 2010
, 2010, 'Management of high grade PMP', presented at 7th International Workshop on Peritoneal Surface Malignancy, Uppsala, Sweden, 08 September 2010 - 10 September 2010
, 2010, 'Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: A 19-year experience form an Established Australian Hepatobiliary', presented at Annuals Scientific Congress, Perth Convention Exhibition Centre, Perth, Australia, 04 May 2010 - 07 May 2010
, 2010, 'Evaluation of the effectiveness of a novel anaesthetic protocol in reducing massive blood transfusion during cytoreductive surgery: Can early and aggressive administration of fresh frozen plasma combined with restrictive fluid resuscitation really work?', presented at Annuals Scientific Congress, Perth Convention Exhibition Centre, Perth, Australia, 04 May 2010 - 07 May 2010
, 2010, 'Progression and survival results following radical hepatic metastasectomy of advanced neuroendocrine tumor supports and aggressive surgical approach', presented at Annuals Scientific Congress, Perth Convention Exhibition Centre, Perth, Australia, 04 May 2010 - 07 May 2010
, 2010, 'Down-regulation of tumoral hypoxia-inducible factor-1 alpha expression in OVCAR-3 tumors by albendazole', presented at AACR 101st Annual Meeting, Walter E.Washington Convention Centre, Washington DC, 17 April 2010 - 21 April 2010
, 2010, 'Clinicopathological determinants of survival after hepatic resection on hepatocellular cacinoma in 97 patients - Experience from an Australia Hepatobiliary Unit', presented at 63rd Annual Cancer Symposium, Society of Surgical Oncology, St. Louis, Missouri, 03 March 2010 - 07 March 2010
, 2010, 'Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma', presented at 63rd Annual Cancer Symposium, Society of Surgical Oncology, St. Louis, Missouri, 03 March 2010 - 07 March 2010
, 2009, 'Peritonectomy for colorectal cancer, pseudomyxoma peritonei peritoneal mesothelioma and ovarian cancer', presented at 5th Scientific Conference for Saudi General Surgery Society, King Fahad Medical Research Centre, King Abdulaziz University Jeddah, 19 October 2009 - 21 October 2009
, 2009, 'Systematic review of randomized and nonrandomized trials on the clinical efficacy and safety of neoadjuvant transarterial chemoembolization (TACE)for resectable hepatocellular carcinoma', presented at International Liver Cancer Association 3rd Annual Conference (ILCA), Milan, Italy, 04 September 2009 - 06 September 2009
, 2009, 'Colon cancer', presented at Medical Legal Conference, Amora Hotel, Jamison Street, Sydney Australia, 24 July 2009
, 2009, 'Preoperative and operative risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei', presented at Royal Australasian College of Surgeons Annual Scientific Congress, Brisbane, Australia, 06 May 2009
, 2009, 'Risk factors for massive blood transfusion after cytoreductive surgery and perioperative intraperitoneal chemotherapy', presented at Royal Australasian College of Surgeons Annual Scientific Congress, Brisbane, Australia, 06 May 2009
, 2009, 'Peritonectomy role in advanced/recurrent ovarian cancer', presented at 1st International Conference & Workshop on Up to Date Obstetrics & Gynecology, King Fahad Medical City, Riyadh, 13 April 2009 - 15 April 2009
, 2009, 'Cytoreductive surgery', presented at National Symposium on Update of Oncology & Lymphoma, King Fahad Specialist Hospital Buraidah, Al Qassim & Prince Faisal Bin Bandar Cancer Centre, 08 April 2009
, 2009, 'Differential expression of Ki-67, estrogen receptor, and progesterone receptor between genders in peritoneal mesothelioma: An immunohistochemistry study that provides a plausible explanation for the better prognosis in females?', presented at Annual Cancer Symposium Society of Surgical Oncology, Phoenix Arizona, USA, 04 March 2009 - 08 March 2009
Conference Abstracts
, 2023, 'ASO Visual Abstract: Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians', in Annals of surgical oncology, Vol. 30, pp. 3346 - 3347, http://dx.doi.org/10.1245/s10434-022-12857-7
, 2019, 'Prognostic value of the volume time index (VTI) ratio for patients with appendiceal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 37, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2019 - 04 June 2019, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.e15704
, 2015, 'Monepantel a new first in class potent inhibitor of P70S6K potentiates the anti-tumor effects of gemcitabine and doxorubicin: In vitro and in vivo studies', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-LB-005
, 2015, 'Synergistic inhibition of human gastric and colorectal cancers by Bromelain and N-acetylcysteine: An in vivo study', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-LB-007
, 2015, 'BROMELAIN AND N-ACETYLCYSTEINE INHIBIT PROLIFERATION AND SURVIVAL OF GASTROINTESTINAL CANCER CELLS: SIGNIFICANCE OF COMBINATION THERAPY', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, FRANCE, Paris, Vol. 26, pp. 27 - 27, presented at 13th International Congress on Targeted Anticancer Therapies (TAT), FRANCE, Paris, 02 March 2015 - 04 March 2015, http://dx.doi.org/10.1093/annonc/mdv094.6
, 2015, 'IN VIVO ASSESSMENT OF GROWTH-INHIBITORY AND MUCIN-DEPLETING EFFECTS OF BROMELAIN AND N-ACETYLCYSTEINE IN PERITONEAL CARCINOMATOSIS MODELS', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, FRANCE, Paris, Vol. 26, pp. 28 - 28, presented at 13th International Congress on Targeted Anticancer Therapies (TAT), FRANCE, Paris, 02 March 2015 - 04 March 2015, http://dx.doi.org/10.1093/annonc/mdv095.3
, 2015, 'SPROUTY 2 PROTEIN, BUT NOT SPROUTY 4, IS AN INDEPENDENT PROGNOSTIC BIOMARKER FOR HUMAN EPITHELIAL OVARIAN CANCER', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, FRANCE, Paris, Vol. 26, pp. 22 - 22, presented at 13th International Congress on Targeted Anticancer Therapies (TAT), FRANCE, Paris, 02 March 2015 - 04 March 2015, http://dx.doi.org/10.1093/annonc/mdv092.4
, 2014, 'EFFECT OF NON-PARALLEL PLACEMENT OF INCIRCLE BIPOLAR RADIOFREQUENCY ABLATION PROBES ON VOLUME OF TISSUE ABLATED WITH HEAT SINK', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Vol. 50, pp. E65 - E65, http://dx.doi.org/10.1016/j.ejca.2014.03.246
Patents
, 2023, Treatment of diseases involving mucin, Canada, Patent No. 2895149
, 2023, Compositions and methods for the treatment of diseases involving mucin, Europe, Patent No. 3362085
, 2022, Treatment of diseases involving mucin, Patent No. United States 11369666
, 2019, Treatment of diseases involving mucin, Patent No. Denmark patent no. 2931296; Hong Kong patent no. HK1211213, https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160520&DB=&locale=en_EP&CC=HK&NR=1211213A1&KC=A1&ND=4
, 1997, Method and apparatus for the prevention of venous thrombosis, Patent No.
, 1997, Method of treatment of Hepatoma and Pharmaceutical Compositions for use therein, Patent No.
, 1997, Use of tumor associated Glycoproteins in transplantation, Patent No.
Preprints
, 2024, Effect of Nebulised BromAc<sup>®</sup> on Mucus Plug in a Mechanically Ventilated Ex-Vivo Ovine Lung Model for Obstructive Respiratory Tract, http://dx.doi.org/10.20944/preprints202406.1231.v1
, 2022, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: Lessons from 20 years experience, http://dx.doi.org/10.21203/rs.3.rs-1773366/v1
, 2022, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: Lessons from 20 years' experience, http://dx.doi.org/10.21203/rs.3.rs-1773366/v2
, 2021, Bromelain and acetylcysteine (BromAc (R)) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancreatic cancer after intraperitoneal injection, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000740417800011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, Effect of nebulised BromAc® on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases including COVID-19, http://dx.doi.org/10.1101/2021.12.28.474344
, 2021, Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19, http://dx.doi.org/10.1101/2021.12.23.21268347
Filter by type
https://orcid.org/0000-0001-9377-8521